NCT07029126View on ClinicalTrials.gov

Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

March 30, 2026

Conditions
Migraine
Interventions
DRUG

Fremanezumab

subcutaneous injection 225 mg monthly or 675 mg quarterly

Trial Locations (10)

00145

RECRUITING

Fondazione Policlinico Universitario Campus Bio-Medico, Rome

Unknown

RECRUITING

"Ospedali Riuniti Umberto I- GM LANCISI G.SALESI", Ancona

RECRUITING

"PO Avezzano S.Filippo e Nicola", Avezzano

RECRUITING

"Clinica Neurologica L. Amaducci Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari", Bari

RECRUITING

IRCCS Istituto Scienze Neurologiche, Bologna

RECRUITING

ASST Spedali Civili Brescia, Brescia

RECRUITING

"Fondazione IRCCS Istituto Neurologico Carlo Besta", Milan

RECRUITING

"Dipartimento delle scienze avanzate mediche e chirurgiche, Università della Campania Luigi Vanvitelli", Naples

RECRUITING

IRCCS San Raffaele Pisana, Rome

RECRUITING

Ospedale Fabenefratelli- San Pietro, Rome

All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER